News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
713,527 Results
Type
Article (46145)
Company Profile (301)
Press Release (667081)
Section
Business (208976)
Career Advice (2229)
Deals (36278)
Drug Delivery (106)
Drug Development (82573)
Employer Resources (174)
FDA (16307)
Job Trends (15235)
News (352820)
Policy (33215)
Tag
Academia (2577)
Alliances (50901)
Alzheimer's disease (1336)
Approvals (16281)
Artificial intelligence (212)
Bankruptcy (367)
Best Places to Work (11742)
Biotechnology (221)
Breast cancer (228)
Cancer (1757)
Cardiovascular disease (136)
Career advice (1845)
CAR-T (131)
Cell therapy (378)
Clinical research (66452)
Collaboration (697)
Compensation (370)
COVID-19 (2625)
C-suite (169)
Data (1648)
Diabetes (212)
Diagnostics (6350)
Earnings (86326)
Employer resources (152)
Events (114701)
Executive appointments (579)
FDA (17222)
Funding (625)
Gene therapy (269)
GLP-1 (679)
Government (4414)
Healthcare (18919)
Infectious disease (2740)
Inflammatory bowel disease (129)
Interviews (354)
IPO (16774)
Job creations (3933)
Job search strategy (1588)
Layoffs (458)
Legal (8122)
Lung cancer (257)
Manufacturing (250)
Medical device (13310)
Medtech (13315)
Mergers & acquisitions (19873)
Metabolic disorders (569)
Neuroscience (1765)
NextGen: Class of 2025 (6672)
Non-profit (4523)
Northern California (2120)
Obesity (316)
Opinion (237)
Patents (166)
People (58534)
Phase I (20785)
Phase II (29325)
Phase III (21716)
Pipeline (735)
Postmarket research (2592)
Preclinical (8769)
Radiopharmaceuticals (244)
Rare diseases (343)
Real estate (6254)
Regulatory (22421)
Research institute (2367)
Resumes & cover letters (376)
Southern California (1812)
Startups (3824)
United States (18775)
Vaccines (647)
Weight loss (223)
Date
Today (92)
Last 7 days (607)
Last 30 days (2686)
Last 365 days (35268)
2025 (4548)
2024 (36004)
2023 (40721)
2022 (51906)
2021 (56395)
2020 (54706)
2019 (47174)
2018 (35621)
2017 (33149)
2016 (32609)
2015 (38485)
2014 (33868)
2013 (29005)
2012 (29481)
2011 (30133)
2010 (28206)
Location
Africa (801)
Arizona (214)
Asia (39541)
Australia (6636)
California (4838)
Canada (1725)
China (406)
Colorado (219)
Connecticut (234)
Europe (86078)
Florida (693)
Georgia (165)
Illinois (483)
Indiana (263)
Maryland (754)
Massachusetts (3677)
Michigan (199)
Minnesota (344)
New Jersey (1374)
New York (1372)
North Carolina (868)
Northern California (2120)
Ohio (174)
Pennsylvania (1112)
South America (1188)
Southern California (1812)
Texas (711)
Utah (144)
Washington State (477)
713,527 Results for "janssen biotech inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Executive appointments
Women Leaders Decline in Biotech’s Era of ‘Proven Leadership’
Of the 102 company launches or series A financings since October 2023, just nine had a woman at the helm, according to a
BioSpace
analysis. This is happening in an era of biotech where new company founders are searching for CEOs with a track record.
February 5, 2025
·
8 min read
·
Annalee Armstrong
Genetown
Elektrofi and Janssen Biotech Enter Worldwide Collaboration and License Agreement to Exclusively Develop up to Five Programs Utilizing Elektrofi’s Formulation Technology
Elektrofi, Inc. announced that it has entered a multi-target worldwide research collaboration and license agreement with Janssen Biotech, Inc., a Johnson & Johnson company.
January 3, 2024
·
2 min read
Legal
Novo Seeks $830M in Fraud Case Against Singaporean Biotech Over Kidney Drug
Back in 2023, Novo Nordisk committed up to $1.3 billion for a hypertension and kidney disease drug from KBP Biosciences. Now, the pharma giant claims to have been misled by the biotech’s founder—and a judge seems to agree.
February 18, 2025
·
1 min read
·
Annalee Armstrong
Cystic Fibrosis
Cystic Fibrosis Biotech Sionna Announces $150M IPO
The Massachusetts-based biotech plans to use the funds to push its candidates into mid-stage clinical trials in a space dominated by Vertex.
February 3, 2025
·
1 min read
·
Dan Samorodnitsky
BioCapital
AbelZeta Announces Amendment to Worldwide Collaboration and License Agreement with Janssen to Include China
AbelZeta Pharma, Inc. announced an amendment of its worldwide collaboration and license agreement with Janssen Biotech, Inc., a Johnson & Johnson company.
December 14, 2023
·
5 min read
Leadership
Biotech CEO Sisterhood Fills ‘Unmet Need’ for Fellowship Among Women Leaders
At the J.P. Morgan Healthcare Conference, the Biotech CEO Sisterhood assembled in Union Square to showcase the large group of women and allies in biopharma as their authentic selves.
February 5, 2025
·
4 min read
·
Annalee Armstrong
Press Releases
Spine BioPharma, Inc. to Present at Biotech Showcase 2025
January 7, 2025
·
1 min read
Press Releases
Exicure, Inc. Partners with GPCR Therapeutics to Fuel New Growth in Biotech
December 26, 2024
·
4 min read
Venture Capitalists
Novo-Backed Oral Medicine Biotech Adds Lilly to Investors in $93M Series A
Orbis emerged from stealth in February 2024 with $28.1 million in seed funding. The Danish biotech, which aims to flip biologics into oral medicines, has now raised another $93 million.
January 6, 2025
·
1 min read
·
Annalee Armstrong
Venture capitalists
Lilly Partners With a16z on $500M VC Fund for Early-Stage Biotechs
The Biotech Ecosystem Venture Fund will combine the sourcing capabilities of venture capital firm Andreessen Horowitz (a16z) with Eli Lilly’s expertise in R&D—plus half a billion in capital from the Big Pharma.
January 10, 2025
·
1 min read
·
Annalee Armstrong
1 of 71,353
Next
